Form 4: Assembly Biosciences Director Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Director John G. McHutchison sold 1,206 shares of Assembly Biosciences (ASMB) on April 1, 2024, to cover tax withholding obligations related to vested restricted stock units.
Summary
- On April 1, 2024, John G. McHutchison, a director of Assembly Biosciences, sold 1,206 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- The shares were sold at a weighted average price of $13.0719, with individual transactions ranging from $12.90 to $13.30.
- Following the transaction, McHutchison beneficially owns 21,221 shares of Assembly Biosciences.
- The reported number of shares beneficially owned reflects an equitable adjustment resulting from a 1-for-12 reverse stock split that occurred on February 9, 2023.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sell-to-cover) and doesn't contain any information that would significantly impact sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation for directors and officers. This transaction is not necessarily indicative of the director's view of the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 02/09/2023 | 1-for-12 reverse stock split of Assembly Biosciences' common stock. |
| 04/01/2024 | Sale of 1,206 shares by director John G. McHutchison. |
| 04/02/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.